A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for weight loss in a head-to-head trial with semaglutide (Ozempic, Wegovy). It's important to point out that the study was funded by the company that makes Zepbound. But experts aren't surprised by the findings.

Women taking popular weight-loss drugs have been urged to use effective contraception while taking the medication amid reports of a so-called "Ozempic babies" phenomenon. The advice was issued by the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA),

It is also known for being an effective weight loss drug. But the benefits are often accompanied by adverse effects. Some of them, including nausea and constipation, are quite common. But the list is simply growing,